Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery

被引：0
|
作者：
Schwenkglenks, M. [1 ]
Pettengell, R. [2 ]
Culakova, E. [3 ]
Lyman, G. H. [3 ]
机构：
[1] Univ Basel, European Ctr Pharmaceut Med, Impact Neutropenia Chemotherapy European Study Gr, Basel, Switzerland
[2] St Georges Univ, Impact Neutropenia Chemotherapy European Study Gr, London, England
[3] Duke Univ, Awareness Neutropenia Chemotherapy Study Grp, Durham, NC USA
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)71916-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：567 / 567
页数：1
相关论文
共 50 条
  • [21] Development of ABVD as standard treatment for Hodgkin's lymphoma (HL)
    Cheson, B. D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 8 - 8
  • [22] Bladder Carcinoma after ABVD Chemotherapy for Hodgkin's Lymphoma: A Case Report
    Gangopadhyay, Aparna
    Nath, Partha
    Khan, Mofizur Rahman
    Biswas, Jaydip
    CASE REPORTS IN ONCOLOGY, 2012, 5 (01): : 148 - 153
  • [23] Maternal ABVD chemotherapy for Hodgkin lymphoma in a dichorionic diamniotic pregnancy: a case report
    Camille Cotteret
    Yen-Vi Pham
    Ambroise Marcais
    Marine Driessen
    Salvatore Cisternino
    Joël Schlatter
    BMC Pregnancy and Childbirth, 20
  • [24] Maternal ABVD chemotherapy for Hodgkin lymphoma in a dichorionic diamniotic pregnancy: a case report
    Cotteret, Camille
    Pham, Yen-Vi
    Marcais, Ambroise
    Driessen, Marine
    Cisternino, Salvatore
    Schlatter, Joel
    BMC PREGNANCY AND CHILDBIRTH, 2020, 20 (01)
  • [25] Patterns of relapse in PET staged advanced Hodgkin lymphoma treated with ABVD chemotherapy
    Lapuz, C.
    Capp, A.
    O'Brien, P.
    Gupta, S.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S723 - S724
  • [26] Neutropenia occurrence and predictors of reduced chemotherapy delivery: results from the INC-EU prospective observational European neutropenia study
    Ruth Pettengell
    Matthias Schwenkglenks
    Robert Leonard
    André Bosly
    Robert Paridaens
    Manuel Constenla
    Thomas D. Szucs
    Christian Jackisch
    Supportive Care in Cancer, 2008, 16 : 1299 - 1309
  • [27] Neutropenia occurrence and predictors of reduced chemotherapy delivery: results from the INC-EU prospective observational European neutropenia study
    Pettengell, Ruth
    Schwenkglenks, Matthias
    Leonard, Robert
    Bosly, Andre
    Paridaens, Robert
    Constenla, Manuel
    Szucs, Thomas D.
    Jackisch, Christian
    SUPPORTIVE CARE IN CANCER, 2008, 16 (11) : 1299 - 1309
  • [28] Management of fertility in patients receiving ABVD as first line chemotherapy for Hodgkin's Lymphoma
    Xu, K.
    Cox, C.
    Iyengar, S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 : 92 - 93
  • [29] A SYSTEMATIC REVIEW COMPARING BEACOPPESCALATED AND ABVD-LIKE CHEMOTHERAPY FOR HODGKIN LYMPHOMA PATIENTS
    Brillant, C.
    Bauer, K.
    Herbst, C.
    Monsef, I.
    Skoetz, N.
    Engert, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 367 - 368
  • [30] Diffusion lung capacity changes in Hodgkin lymphoma patients before and after ABVD chemotherapy
    Abdullah, Muhammad
    Alam, Shoaib
    Zafar, Waleed
    Majid, Abdul
    Wahla, Ali Saeed
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
12345